IgY neutralizing antibody for resisting novel coronavirus as well as preparation method, preparation and application of IgY neutralizing antibody
The invention provides an efficient anti-novel coronavirus specific IgY neutralizing antibody prepared by utilizing a novel coronavirus spike protein extracellular region (S-ECD protein) and a spike protein receptor binding domain (RBD) to immunize poultry (hens) or birds (female ostriches). The invention also provides anti-novel coronavirus IgY antibody I-type and II-type preparations developed by using the neutralizing antibody. The anti-novel coronavirus IgY antibody I-type and II-type preparations comprise an I-type inhalation atomization spray, an infusion injection and an II-type external liniment. The invention also provides a novel coronavirus prevention and treatment drug containing the antibody and a preparation. The invention further provides application of the antibody and thepreparations in novel coronavirus prevention and treatment medicines..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 18. Dez. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LI JING [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-12-18, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN112094341 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011330546 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011330546 | ||
| 003 | DE-627 | ||
| 005 | 20230504132628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210601s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA011330546 | ||
| 035 | |a (EPA)CN112094341 | ||
| 035 | |a (EPA)73750780 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LI JING |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a IgY neutralizing antibody for resisting novel coronavirus as well as preparation method, preparation and application of IgY neutralizing antibody |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-12-18, Last update posted on www.tib.eu: 2022-04-10, Last updated: 2023-02-09 | ||
| 520 | |a The invention provides an efficient anti-novel coronavirus specific IgY neutralizing antibody prepared by utilizing a novel coronavirus spike protein extracellular region (S-ECD protein) and a spike protein receptor binding domain (RBD) to immunize poultry (hens) or birds (female ostriches). The invention also provides anti-novel coronavirus IgY antibody I-type and II-type preparations developed by using the neutralizing antibody. The anti-novel coronavirus IgY antibody I-type and II-type preparations comprise an I-type inhalation atomization spray, an infusion injection and an II-type external liniment. The invention also provides a novel coronavirus prevention and treatment drug containing the antibody and a preparation. The invention further provides application of the antibody and thepreparations in novel coronavirus prevention and treatment medicines. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHANG BO |4 aut | |
| 700 | 0 | |a LI HUIJUN |4 aut | |
| 700 | 0 | |a HEI AILIAN |4 aut | |
| 700 | 0 | |a FANG CONG |4 aut | |
| 700 | 0 | |a TAN JUNYE |4 aut | |
| 700 | 0 | |a GAO PENG |4 aut | |
| 700 | 0 | |a ALLEN HE |4 aut | |
| 700 | 0 | |a SVEN SKOG |4 aut | |
| 700 | 0 | |a ZHOU JI |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 18. Dez. |
| 773 | 1 | 8 | |g year:2020 |g day:18 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/73750780/publication/CN112094341A1?q=CN112094341 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2020 |b 18 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 18 |c 12 | ||